A COVID vaccine being developed by New Jersey-based Johnson & Johnson could dramatically speed up the fight against the pandemic because, unlike the two vaccines already in use, this one would require only one dose and would not need to be stored at super-cold temperatures.
Trending:
Potential 'game-changer': Hopes high for Johnson & Johnson COVID vaccine if authorized